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A B S T R A C T
Purpose: We conducted a comprehensive review of the epidemiology of epilepsy in the Arab world.
Methods: Epidemiological literature about epilepsy from 22 countries of the Arab League was searched
in French and English using several keywords (speciﬁc and wider) and combinations, individually for
each country. The search was conducted on Google ﬁrst and then on PubMed. The results are presented
as counts, proportions, and medians along with 95% conﬁdence intervals (CI). Unpaired t-test with
unequal variance and regressions were performed, altogether and individually, for lifetime and active
epilepsy prevalence as well as incidence.
Results: Google provided 21 prevalence, four camp and nine incidence estimates while PubMed provided
ten such estimates; none of them was identiﬁed by Google. No epidemiological data about epilepsy was
found from 10/22 countries. Excluding pediatric studies, 13 prevalence estimates from six countries
were identiﬁed. Including pediatric studies, 21 estimates from nine countries were found. Median
lifetime and active epilepsy prevalence were 7.5/1000 (95% CI 2.6–12.3, range 1.9–12.9) and 4.4/1000
(95% CI 2.1–9.3, range 2.1–9.3), respectively, excluding pediatric studies (1984–2014, N = 244081).
Median incidence was 56.0/100,000 (n = 9, N = 122484, 95% CI 13.7–147.9, range 10.4–190).
Conclusion: The fact that no epidemiological data about epilepsy is available in the public domain for
almost one half of all Arab countries offers opportunities for future research. This thorough review of
existing literature demonstrates a prevalence of epilepsy three times higher than previously reported for
this region. The median incidence is similar to other regions of the world, e.g. North America. Google
yielded additional valuable sources not indexed in PubMed and provided pertinent references more
quickly.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Epilepsy is a major neurological disorder and is widely present
across the world [1,2]. So far, studies on epilepsy have mostly been
focused on the African nations although other regions are expected* Corresponding author at: Nepal Interest Group of Epilepsy and Neurology, PO
Box 4240, Kathmandu, Nepal. Tel.: +33 785409113.
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reto have similar or even greater epilepsy-related needs [1]. The Arab
world is unique in terms of mixed ethnicity, varied religious
practices (related to food and substances, marriage) and disease
epidemiology [3,4]. A previous review on epilepsy from this region
estimated the prevalence of epilepsy to be 2.3/1000 [5]. This is
quite likely to be an underestimate for a region as complex and
diverse as the Arab world, but more importantly for the reason that
this review had not included French literature in spite of the
fact that many countries of this region are native French speaking.
Also, this review had used PubMed alone for literature search,served.
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English is not the native language, and where scientiﬁc capacity is
underdeveloped in comparison to other more developed regions
such as Europe or North America. Interestingly, they had also taken
into account hospital-based studies, but despite this the median
epilepsy prevalence proposed for this Arab region was merely 2.3/
1000. In view of these shortcomings, we considered it necessary to
conduct a more comprehensive review of both English and French
literature, adapted to the regional particularities, in order to better
elucidate the burden of epilepsy in this region.
2. Methods
2.1. Search strategy
We searched literature on epilepsy in the Arab world, published
in both English and French. These were obtained via Google and
PubMed, using speciﬁc keywords and their combinations: epilep-
sy, convulsive disorders, seizure disorder, Arab, epilepsie, crise
e´pileptique, crise convulsive, Arabe, and the name of individual
countries. The search was conducted principally on Google,
followed by a similar search on PubMed. No restrictions were
made pertaining to the year of publication. On Google, only the ﬁrst
ﬁve pages were taken into consideration while on PubMed, all the
results were looked at (titles ﬁrst, then abstracts, then full-text) for
identifying suitable studies. Our target approach was to identify all
formal and informal estimates of the prevalence and incidence of
epilepsy by including studies that were population based, and had
clearly deﬁned methodological parameters. The bibliography of
each of these articles was thoroughly looked into as well.
2.2. Deﬁnitions
The Arab world was deﬁned as the 22 member states of the Arab
League. According to the International League against Epilepsy
(ILAE), active epilepsy is deﬁned as ‘‘atleast one epileptic seizure in
the last ﬁve years, irrespective of treatment’’. Treatment gap is
generally deﬁned as ‘‘the difference between the number of people
with active epilepsy and the number being appropriately treated.’’
2.3. Statistical analyses
We performed statistical analysis by using Stata, 2009. t-Test
(unpaired, unequal variance) was used to determine statistical
signiﬁcance of differences, if any, between groups or estimates.
Regression results were derived for population size, age group,
year of study, gross domestic product (GDP) in the year of survey,
and treatment gap, together and individually. A scatter plot with
error margins was plotted by using Microsoft Excel. The resultsTable 1
Studies of lifetime prevalence of epilepsy in children in the Arab world.
Country R/U Year N P/1000 A
Egypt [24] U 2012 12093 9.0 D
Egypt [25] U 2009 8750 7.2 R
r
p
Egypt [25] U 2009 120 133.3 R
d
p
Egypt [20] U 1992 – 10.0 R
Egypt [35] Both 2013 8027 7.3 D
Iraq [26]* – 2005 – 1.0 R
Morocco [27] U 1998 – 11.0 –
Sudan [19] U 1979 – 0.9 E
DTD, door-to-door; EEG, electroencephalogram; P, prevalence; R, rural; U, urban; N, powere derived separately for lifetime and active epilepsy preva-
lence, and incidence of epilepsy. The results have been presented in
terms of counts, proportions, and medians alongwith respective
95% conﬁdence intervals (CI).
3. Results
Overall, no prevalence or incidence estimates on epilepsy were
available from the following ten countries; namely Bahrain,
Comoros, Djibouti, Jordan, Kuwait, Lebanon, Mauritania, Oman,
Qatar, Yemen. We obtained 13 prevalence estimates (excluding
pediatric studies) from six countries and if pediatric studies were
included; it summed up to 21 prevalence estimates from nine
countries. In addition, four estimates of the prevalence of epilepsy
consultations (per 1000) were identiﬁed that were based on
extremely large United Nations’ refugee (Syria, Somalia) camp
population. Further, nine incidence estimates were identiﬁed from
three countries, namely Algeria, Egypt and Palestine. On PubMed,
1285 titles were looked at from 22 countries but only 10 studies
(pertaining to Algeria, Egypt, Libya, Saudi Arabia, Sudan and
Tunisia) were obtained. Each of these had already been identiﬁed
during our primary search on Google.
3.1. Prevalence (lifetime and active)
Excluding pediatric (Table 1) and camp population studies, the
lifetime prevalence of epilepsy (1984–2014, N = 244081) was
reported by 12 studies and the median lifetime prevalence of
epilepsy was estimated to be 7.5/1000 (95% CI 2.6–12.3, range 1.9–
12.9). After including pediatric studies, the median lifetime
prevalence of epilepsy increased to 7.8 (n = 19, 95% CI 5.6–10.9,
range 0.9–133.3), (Fig. 1).
Excluding pediatric (Table 1) and camp population studies, the
prevalence of active epilepsy was reported by only four studies
(Table 2) excluding children and camp studies, and the median
prevalence of active epilepsy was estimated to be 4.4/1000 (95% CI
2.1–9.3, range 2.1–9.3). No active epilepsy estimates were
available from pediatric studies. Uni- and multivariate regression
of lifetime epilepsy for population size, age group, year of study
and GDP was not signiﬁcant (p > 0.05).
Among children, eight epilepsy prevalence estimates were
identiﬁed (N = 28,990, 1979–2013) from four countries, namely
Egypt, Iraq, Morocco and Sudan. The median lifetime prevalence
of epilepsy was estimated to be 8.1 (95% CI 0.96–50.7, range 0.9–
133.3). Treatment gap varied from 20.0% in Sudan to 84.5% in
Egypt. The frequency of generalized epilepsy varied from 62.0%
to 93.8%, and that of partial epilepsy varied from 6.3% to 58.7%;
these data were available from Egypt alone. Only two studies
(from Egypt) [6,33] reported gender-speciﬁc prevalence ofdditional comments
TD among children; neurologist-diagnosis and EEG + Scan
andom sample of conventional schools, health insurance system, school doctor
ecords, school health visitor records, ﬁlling of questionnaire by parents and
arent’s interview neurologist-diagnosis and EEG
andom sample of schools for mentally retarded, health insurance system, school
octor records, school health visitor records, ﬁlling of questionnaire by parents and
arent’s interview; neurologist-diagnosis and EEG
andom sample of school children <15 years age
TD; neurologist-diagnosis; Psychiatrist, and EEG + Scan; children 0–14 years;
efer footnote
ntire school population, hospital and private clinics
pulation size; *government estimate.
Fig. 1. Plotted description of lifetime prevalence of epilepsy in the Arab world.
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1000 among females. None of the results was found to be
signiﬁcant (p > 0.05) upon regression for population size, year of
study, GDP, and treatment gap.
3.2. Incidence of epilepsy
We identiﬁed nine estimates of epilepsy incidence from three
countries (Table 3). It varied from 10.4/100,000 in Palestine to
190.0/100,000 in Algeria. The median incidence of epilepsy was
estimated to be 56.0 (N = 122484, 95% CI 13.7–147.9). ThisTable 2
Prevalence studies of epilepsy in the Arab world.
Country R/U Year Age N P-L 
Algeria [28] Both 2012 All ages 8046 8.3 
Algeria [29] – 2002 – – 1.9 
Algeria [30] U 2011 >2 months 3002 12 
Egypt [31] Both 2010 All ages 6498 12.6 
Egypt [32] U 2012 All ages 33283 5.5 
Egypt [33] – 2008 All ages 62583 6.7 
Egypt [34] Both 2008 All ages 62583 2.1 
Egypt [35] Both 2013 All ages 8027 12.4 
Libya [17] U 1984 Adults > 15 – 2.3 
Saudi [36] U 1995 All ages 1485 10.2 
Saudi [37] U 1989 All ages 23700 6.5 
Tunisia [38] – 1985 All ages 34874 – 
UAE [39]* Both 2014 All ages 12.9 
DTD, door-to-door; EEG, electroencephalogram; *Unofﬁcial estimate; MOH, Ministry of
1000; R, Rural; U, urban.indicates that 204,777 new cases of epilepsy are likely to be
occurring every year in this region. None of the results was found to
be signiﬁcant (p > 0.05) upon regression for population size, year
of study and GDP. However, incidence estimates were found to be
statistically different from each other (Egypt studies only) with
p = 0.0004.
4. Discussion
We conducted a comprehensive review of epilepsy in the Arab
world to provide regional estimate of the prevalence and incidenceP-A Additional comments
– Randomly selected primary care clinics of ﬁve regions;
neurologist-diagnosis and EEG + Scan
– MOH survey
– Random sample of private and public practitioners and
pediatricians of 5 regions; neurologist-diagnosis
9.3 DTD; neurologist-diagnosis and EEG + Scan
– DTD for multiple neurological disorders; neurologist-diagnosis
4.9 DTD; neurologist-diagnosis and EEG + Scan
– DTD for uncontrolled epilepsy; neurologist-diagnosis and
EEG + Scan
2.1 DTD; neurologist-diagnosis; Psychiatrist, and EEG + Scan
– Polyclinics, EEG labs, university hospitals; DTD; neurologist-
diagnosis; and EEG + Scan
– DTD for multiple neurological disorders; DTD; neurologist-
diagnosis
– DTD of restricted area; DTD; neurologist-diagnosis; and
EEG + Scan
4.0 DTD for multiple neurological disorders; neurologist-diagnosis
– Refer footnote
 Health; N, population size; P-A, prevalence active/1000; P-L, prevalence lifetime/
Table 3
Studies of incidence of epilepsy in the Arab world.
Country R/U Year Age N I Additional comment
Algeria 1 [29] – 2006 All – 190 MOH survey
Algeria 2 [28] – 1977 – – 56 Randomly selected primary care clinics nation-wide; neurologist-diagnosis
and EEG + Scan
Egypt 1 [33] Both 2008 All 62583 43.1 DTD; neurologist-diagnosis and EEG + Scan
Egypt 2 [24] – 2012 C 12093 82.7 DTD among children; neurologist-diagnosis and EEG + Scan
Egypt 3 [31] Both 2010 All 6498 150 DTD; neurologist-diagnosis and EEG + Scan
Egypt 4 [32] U 2012 All 33283 48 DTD for multiple neurological disorders; neurologist-diagnosis
Egypt 5 [35] Both 2013 All 8027 123 DTD; neurologist-diagnosis; Psychiatrist, and EEG + Scan
Palestine [40] – 2013 – – 11.3 MOH/thesis estimate
Palestine [41] – 2005 All – 10.4 MOH survey
C, children; DTD, door-to-door; EEG, electroencephalogram; I, incidence/100,000; MOH, Ministry of Health; N, population size; R, rural; U, urban.
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methodology, we were able to incorporate a higher number of
studies into our analysis, than what has been hitherto done [5], and
therefore come up with ﬁgures that are more reﬂective of the true
burden of epilepsy in this region. Our use of a varied combination
of keywords, no restriction on the year of publication, consider-
ation of French literature and the use of a more general search
engine like Google, inclusion of sources such as thesis, reports and
conference abstracts among others which cannot be retrieved from
PubMed, were some necessary qualities for this difference.
Largely, epilepsy has not been systematically evaluated and
reported in this region as is the case with some of the other regions
as well, particularly Asia [1]. As mentioned earlier, ten out of
22 countries do not have any fundamental data on epilepsy as of
yet, reﬂecting the possibility of lower importance given to epilepsy
in such scientiﬁcally-silent countries. The general paucity of this
precious fundamental data rules out the possibility of local
evidence-based public health interventions or the establishment
of formal health programs dedicated to epilepsy by engaging key
local stakeholders as has been done in Cambodia and Laos, for
example [7,8]. At the same time, this also accentuates the role of
international parent organizations like the ILAE and the World
Health Organization in the betterment of this scenario.
Nine countries however were found to have some fundamental
prevalence data on epilepsy representing 41.0% (45.5% if both
prevalence and incidence data combined) of this region. This
situation is better than other regions, namely Asia [1]. There are
some Arab world countries, particularly Syria [4] and Somalia [9]
that have experienced a considerable displacement of their
population to refugee camps in their own or in other countries.
These camps, belonging to the United Nations, are extremely large,
with that of Somalia being the largest in the world [9]. Reports
based on these populations could have been an additional source of
valuable epilepsy data for these two countries. However, according
to source reports, it is the frequency of consultations for epilepsy
that has been reported from these camps, instead of the number
of incident or prevalent cases of epilepsy or the population
denominator.
As elsewhere [10,11] more emphasis has been placed on the
lifetime epilepsy as compared to active epilepsy. This approach
fails to accurately elucidate the burden of disease in need of active
intervention. Based on available data (including children studies),
we determined that only 56.4% of the total epilepsy case load in
this region comprises of patients with active disease and therefore
in true need of treatment. This is less than some countries where
approximately 93% of those with lifetime epilepsy have active
seizures [7]. Similarly, in Latin America (currently unpublished, D
Bhalla), 64.0% of the total epilepsy case load requires active
intervention. These differences are important in understanding the
truer disease burden that is unique to each country or the region,
and the true need of resources.Our estimate of the median prevalence turned out to be much
higher at 7.5/1000, in comparison to 2.3/1000 [5] that had been
previously reported for this region. This difference can be
accounted for by the robustness of the methodology we had
adopted. This difference also compels us to reﬂect upon the various
risk factors for epilepsy that are unique to this region. Consan-
guinity is extensively prevalent in Arab countries, some of which
show the highest rates in the world with marriage among ﬁrst
cousins comprising >60% of all unions [3]. In Algeria, where
prevalence of epilepsy is 8.3/1000, the rate of inbreeding is also
high, i.e. close to 40% [12]. Some Arab countries like Qatar, Yemen
and UAE are showing an increase in consanguinity rates [3], and
these countries turned out to have high prevalence of epilepsy in
our analysis as well (Table 1). Others like Palestine are
experiencing a decline in consanguinity, and have at the same
time shown comparatively lower prevalence and incidence ﬁgures
[13], (Tables 1 and 2). Although prohibited by the religion,
substance abuse has reached alarming proportions in some of
these Arab world countries, particularly Egypt and Saudi Arabia,
where prevalence of epilepsy is also high (Tables 1 and 2)
[14]. Likewise, given the fact that the religion prohibits swine
breeding and consumption of pork, neurocysticercosis has
traditionally been considered to be non-existent in this region.
However, literature suggests that the prevalence of neurocysti-
cercosis in the Arab world has been increasing over the past few
years [15]. A lot of these countries host migrant population from
South East Asia where neurocysticercosis is a common occurrence,
a fact that may explain the above ﬁnding. Interestingly, the pattern
of disease expression of neurocysticercosis in the Arab region is
similar to that observed in patients from South East Asia
[16]. Besides these reasons, it was also observed that most studies
had some methodological issues; such as using different recruit-
ment schemes, ages, etc. (Tables 1–3) [17–20].
Similarly, incidence (per 100,000) varied considerably across
countries and median incidence was estimated to be 56.0 (95% CI
13.7–147.9). Besides methodological issues [1], it is likely that the
above factors play a major role in determining the incidence of
epilepsy in this region. Moreover, when compared, the estimates of
epilepsy incidence (Egypt studies only) were statistically different
from one another (p = 0.0004), suggesting the presence of different
within-country determinants and risk factors [21–23].
Regarding limitations in our work, our primary search was
conducted on Google, and was veriﬁed by a similar search on
PubMed. Although we may still have missed out on identifying
some studies, our multi-language, Google-inclusive approach did
ensure that our review had far more number of studies and
estimates as compared to the previous regional reviews. Another
limitation may arise from the variations in the deﬁnition of
epilepsy across studies. We did not devise our own deﬁnition, nor
did we judge which version of the deﬁnition was more appropriate,
and by and large respected the interpretation of individual authors.
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could have increased precision, it would also have signiﬁcantly
decreased the number of studies that could have been ﬁnally
included and may then have not justiﬁed doing an analysis at all.
Active epilepsy, in general, refers to cases that have not yet
resolved, and the patients have not yet clinically outgrown the
condition. Inactive epilepsy, on the other hand, means that the
patient no longer has active disease. However, it does not imply
cure nor does it guarantee that seizures will not occur in the future.
According to the ILAE, active epilepsy is deﬁned as atleast one
epileptic seizure in the last ﬁve years irrespective of treatment.
This deﬁnition was however not used by any of the authors.
Besides these, changes in the reporting practices and parameters
over time may have had some impact on our results. Yet, our target
was to highlight the importance of focusing on active epilepsy vis-
a-vis lifetime epilepsy as the former provides a more accurate
picture of the disease burden, and better identiﬁes those in need of
intervention from public health agencies.
5. Conclusions
Several countries in the Arab world are yet to have any
fundamental data on epilepsy that infact offer opportunities for
conducting novel initiatives on epilepsy in these scientiﬁcally-
silent countries. The prevalence of epilepsy is far higher (about
three-times) than what has been previously reported for this
region. The ﬁrst-ever regional estimate of the median incidence of
epilepsy suggests that the rate is similar to other regions such as
North America. Our work proposes that 1.43 million people have
lifetime epilepsy in this region, and only about 56.0% of them
require active therapeutic interventions for their epilepsy. Also,
204,777 new cases of epilepsy are likely to be occurring every year
in this region. There is an urgent need to standardize methods,
initiate systematic investigations, test interventions, and quantify
many of the Arab world-speciﬁc epilepsy risk factors including
substance abuse, consanguinity, neurocysticercosis, etc. We aimed
to provide an alternative method of literature search especially
suited for regions which are not necessarily English or PubMed
driven and where scientiﬁc capacity is yet to achieve its full
potential, a general search engine like Google can outscore the
more traditional ones like PubMed in terms of both the yield and
the speed at which the results are obtained.
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